Literature DB >> 2019988

Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations.

D Ratge1, K P Kohse, U Steegmüller, H Wisser.   

Abstract

Plasma, platelet and erythrocyte contents of free and conjugated norepinephrine, epinephrine and dopamine were determined by radioenzymatic assay in 12 resting healthy volunteers. Mean platelet/plasma concentration ratios were 533 for free norepinephrine, 502 for free epinephrine and 149 for free dopamine. Corresponding erythrocyte/plasma ratios were 1.04, 1.13 and 4.5, respectively. The presence of conjugated catecholamines in platelets and erythrocytes could be confirmed; however, their relative proportion within these cells, particularly in platelets, was lower than that in plasma. Upon intravenous infusion of dopamine for 3 hr at 5 micrograms kg-1 min-1, concentrations of free dopamine in plasma increased rapidly (280-970-fold), whereas conjugated dopamine only reached maximal values (14-19-fold increase) at 30 to 60 min after cessation of the infusion. The relative distribution of unconjugated dopamine in whole blood between plasma, platelets and erythrocytes changed from mean values of 1:0.33:3.7 at rest to 1:1.1:0.5 at the end of the infusion. As a result of the subsequent rapid decrease of dopamine in plasma and erythrocytes, this distribution was 1:17:1 shortly thereafter and remained constant up to the end of the investigation period. The relative distribution for conjugated dopamine of 1:0.001:0.5 at rest changed to about 1:0.2:0.1 at the termination of the infusion. Oral administration of norepinephrine and dopamine led to increases in the plasma concentrations of these amines in their conjugated forms only, whereas epinephrine concentrations remained constant. These elevations were not accompanied by corresponding increases in platelet and erythrocyte norepinephrine, epinephrine and dopamine contents.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2019988

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Idiopathic hypovolemia: a self-perpetuating autonomic dysfunction?

Authors:  O Kuchel; J Léveillé
Journal:  Clin Auton Res       Date:  1998-12       Impact factor: 4.435

Review 2.  Erythrocytes and the transport of drugs and endogenous compounds.

Authors:  M S Highley; E A De Bruijn
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

3.  Sustained noradrenaline sulphate response in long-distance runners and untrained subjects up to 2 h after exhausting exercise.

Authors:  G Strobel; V Hack; R Kinscherf; H Weicker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

4.  The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines.

Authors:  B Friedgen; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Plasma catecholamines after endotracheal administration of adrenaline during postnatal resuscitation.

Authors:  K O Schwab; H B von Stockhausen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-05       Impact factor: 5.747

6.  Plasma sulpho-conjugated catecholamine dynamics up to 8 h after 60-min exercise at 50% and 70% maximal oxygen uptakes.

Authors:  T Ogaki; A Saito; S Kanaya; T Fujino
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

Review 7.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Excretion of catecholamines in rats, mice and chicken.

Authors:  M Lepschy; S Rettenbacher; C Touma; R G Palme
Journal:  J Comp Physiol B       Date:  2008-02-15       Impact factor: 2.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.